Anti-bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor-binding response, impairing tumor outgrowth.
Sanches, Jéssica de Souza
Anti-bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor-binding response, impairing tumor outgrowth. [electronic resource] - Cancer science Apr 2016 - 551-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1349-7006
10.1111/cas.12903 doi
Angiogenesis Inhibitors--administration & dosage
Animals
Antibodies, Anti-Idiotypic--administration & dosage
Antibodies, Monoclonal--administration & dosage
Bevacizumab--administration & dosage
Cell Line, Tumor
Humans
Melanoma, Experimental--drug therapy
Mice
Neovascularization, Pathologic--drug therapy
Vascular Endothelial Growth Factor A--immunology
Anti-bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor-binding response, impairing tumor outgrowth. [electronic resource] - Cancer science Apr 2016 - 551-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1349-7006
10.1111/cas.12903 doi
Angiogenesis Inhibitors--administration & dosage
Animals
Antibodies, Anti-Idiotypic--administration & dosage
Antibodies, Monoclonal--administration & dosage
Bevacizumab--administration & dosage
Cell Line, Tumor
Humans
Melanoma, Experimental--drug therapy
Mice
Neovascularization, Pathologic--drug therapy
Vascular Endothelial Growth Factor A--immunology